Last updated on March 2019

Metastatic Pancreatic Cancer


Brief description of study

A research study is evaluating an investigational anti-cancer medication in combination with standard of care first line treatment for adults with metastatic pancreatic cancer.

Clinical Study Identifier: TX218108

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.